Objectives-The chronic microcytic anae-
microcytosis is evidence of impaired haemoglobin production. This study has examined possible abnormalities of erythroid haem biosynthesis that may contribute to the anaemia. Methods-5-Aminolaevulinate (ALA) synthase and ferrochelatase activities were assayed in whole bone marrow and in purified erythroblasts from patients with RA and in control subjects. AUR patients were iron replete with demonstrable iron in the bone marrow. Results-ALA synthase activity was significantly reduced in both whole bone marrow and purified erythroblasts from patients with the anaemia of RA. Erythrocyte protoporphyrin levels were raised in nine of 12 patients tested while ferrochelatase activity was normal. Conclusion-These abnormalities provide absolute evidence of abnormal erythroblast haem biosynthesis and iron metabolism in the anaemia ofRA and most likely reflect decreased ALA synthase mRNA translation and some abnormality of erythroblast iron transport. Further studies using highly purified erythroblast populations will attempt to identify the causal factors leading to this abnormal erythroblast metabolism.
(Ann Rheum Dis 1994; 53: 167-170)
The anaemia of rheumatoid arthritis (RA) is multifactorial and in many cases is related to gastro intestinal blood loss associated with the use of nonsteroidal anti-inflammatory agents. In 60% of cases, however, the cause is unknown and the anaemia attributed to the unexplained effects of chronic disease.' This chronic anaemia is characterised in most cases by iron deficient red cell indices2 with reduced serum iron levels despite a paradoxical increase in reticulo endothelial iron stores. Most studies of this anaemia have concentrated on the possible roles of reduced marrow iron supply and impaired erythropoietin (Epo) production or response for which both interleukin 1 (IL-1) and tumour necrosis factor (TNF) have been proposed as possible mediators.3 4 The strong inverse correlation between Epo levels and haemoglobin concentration that characterises most other anaemias is lost. Epo levels may be raised in the majority of patients but the response is blunted by comparison to levels found in anaemias of other aetiologies. 5 The erythroid marrow in inflammation retains the ability to respond to Epo but hormone production is not increased. 16 The hypochromic microcytic red cells in the chronic anaemia of RA provide absolute evidence of haemoglobin deficiency. Elevated erythrocyte protoporphyrin levels have been recognised'3 and so localise the defect in haemoglobin synthesis to either the haem biosynthetic pathway or the iron transport mechanism. We have investigated haem biosynthesis with measurement of 5-Aminolaevulinic acid (ALA) synthase activity and ferrochelatase activity in whole bone marrow and in purified bone marrow erythroblasts. Both enzymes have been proposed as candidate regulators of erythroid haem biosynthesis.'7 18 Protoporphyrin levels were measured in circulating erythrocytes.
Materials and methods

PATIENTS AND CONTROLS
Ethical approval was obtained from Lanarkshire and Glasgow Royal Infirmary Ethical Committees. Bone marrow samples were 
66 (23) 12 (7) EPP = erythrocyte protoporphyrin.
aspirated from the posterior iliac crest in 14 patients with sero positive RA and the anaemia of chronic disease and from 10 normal subjects ( ALA synthase and ferrochelatase activities were assayed in whole bone marrow and in purified marrow erythroblasts using sensitive radiochemical methods which utilise high performance liquid chromatography for product isolation.20 21 Erythrocyte protoporphyrin levels were measured in 12 of the 14 patients and in the 10 normal subjects using a haematofluorimeter (model 206 Aviv Biomedical Inc) and expressed nmolIl RBCs.
Results
ALA SYNTHASE AND FERROCHELATASE ACTIVITY ALA synthase activity was significantly reduced in both whole bone marrow and fractionated erythroblasts from patients with the anaemia of rheumatoid arthritis (fig 1) . Enzyme activity in whole bone marrow will always appear higher than that found in purified erythroblast preparations. In crude whole bone marrow there is a significant myeloid cell contamination which has been shown to contribute some 50% of the total ALA synthase activity.20 Erythroblast ALA synthase activity is further reduced by 30% during the incubation stage required to achieve TG-1 mediated myeloid cell lysis.20 Erythro 
